226 related articles for article (PubMed ID: 33849485)
1. A new risk-stratification system for hepatoblastoma in children under six years old and the significance for prognosis evaluation-a 14-year retrospective study from a single center.
Zhi T; Zhang WL; Zhang Y; Hu HM; Wang YZ; Huang DS
BMC Cancer; 2021 Apr; 21(1):397. PubMed ID: 33849485
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and prognostic factors of hepatoblastoma in 316 children aged under 3 years - a 14-year retrospective single-center study.
Zhi T; Zhang WL; Zhang Y; Hu HM; Huang DS
BMC Pediatr; 2021 Apr; 21(1):170. PubMed ID: 33849474
[TBL] [Abstract][Full Text] [Related]
3. [Clinical features and prognostic analysis of hepatoblastoma in children under six years old].
Zhi T; Zhang WL; Zhang Y; Hu HM; Wang YZ; Huang DS
Zhonghua Gan Zang Bing Za Zhi; 2021 Nov; 29(11):1063-1068. PubMed ID: 34933424
[No Abstract] [Full Text] [Related]
4. Is multifocality a prognostic factor in childhood hepatoblastoma?
Saettini F; Conter V; Provenzi M; Rota M; Giraldi E; Foglia C; Cavalleri L; D'Antiga L
Pediatr Blood Cancer; 2014 Sep; 61(9):1593-7. PubMed ID: 24757164
[TBL] [Abstract][Full Text] [Related]
5. Prognostic stratification for children with hepatoblastoma: the SIOPEL experience.
Maibach R; Roebuck D; Brugieres L; Capra M; Brock P; Dall'Igna P; Otte JB; De Camargo B; Zsiros J; Zimmermann A; Aronson D; Childs M; Scopinaro M; Morland B; Plaschkes J; Czauderna P; Perilongo G
Eur J Cancer; 2012 Jul; 48(10):1543-9. PubMed ID: 22244829
[TBL] [Abstract][Full Text] [Related]
6. Analysis of survival rates and prognosis of hepatoblastoma in children: a retrospective study from a single center in China.
Liu J; Wu XW; Li T; Hao XW; Duan YH; Zhao J; Zhu CZ; Wei B; Dong Q
Pediatr Hematol Oncol; 2021 May; 38(4):319-330. PubMed ID: 33667139
[TBL] [Abstract][Full Text] [Related]
7. Independent Assessment of the Children's Hepatic Tumors International Collaboration Risk Stratification for Hepatoblastoma and the Association of Tumor Histological Characteristics With Prognosis.
Zhou S; Malvar J; Chi YY; Stein J; Wang L; Genyk Y; Sposto R; Mascarenhas L
JAMA Netw Open; 2022 Feb; 5(2):e2148013. PubMed ID: 35147687
[TBL] [Abstract][Full Text] [Related]
8. Predictors of survival after resection of children with hepatoblastoma: A single Asian center experience.
Qiao GL; Li L; Cheng W; Ge J; Zhang Z; Wei Y
Eur J Surg Oncol; 2014 Nov; 40(11):1533-9. PubMed ID: 25103357
[TBL] [Abstract][Full Text] [Related]
9. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.
Meyers RL; Maibach R; Hiyama E; Häberle B; Krailo M; Rangaswami A; Aronson DC; Malogolowkin MH; Perilongo G; von Schweinitz D; Ansari M; Lopez-Terrada D; Tanaka Y; Alaggio R; Leuschner I; Hishiki T; Schmid I; Watanabe K; Yoshimura K; Feng Y; Rinaldi E; Saraceno D; Derosa M; Czauderna P
Lancet Oncol; 2017 Jan; 18(1):122-131. PubMed ID: 27884679
[TBL] [Abstract][Full Text] [Related]
10. Pure fetal histology subtype was associated with better prognosis of children with hepatoblastoma: A Chinese population-based study.
Qiao GL; Chen Z; Wang C; Ge J; Zhang Z; Li L; Ren J
J Gastroenterol Hepatol; 2016 Mar; 31(3):621-7. PubMed ID: 26401976
[TBL] [Abstract][Full Text] [Related]
11. Treatment outcome and pattern of failure in hepatoblastoma treated with a consensus protocol in Hong Kong.
Liu APY; Ip JJK; Leung AWK; Luk CW; Li CH; Ho KKH; Lo R; Chan EKW; Chan ACY; Chung PHY; Chiang AKS
Pediatr Blood Cancer; 2019 Jan; 66(1):e27482. PubMed ID: 30270490
[TBL] [Abstract][Full Text] [Related]
12. Predictors of survival and incidence of hepatoblastoma in the paediatric population.
Allan BJ; Parikh PP; Diaz S; Perez EA; Neville HL; Sola JE
HPB (Oxford); 2013 Oct; 15(10):741-6. PubMed ID: 23600968
[TBL] [Abstract][Full Text] [Related]
13. [Clinical characteristics and prognosis of 83 children with newly treated hepatoblastoma].
Wei LL; Ran Y; Li B; Su SF; Wei HX; Mao ST; Liu YF
Zhonghua Er Ke Za Zhi; 2022 Feb; 60(2):108-113. PubMed ID: 35090226
[No Abstract] [Full Text] [Related]
14. Clinical efficacy and prognosis factors for advanced hepatoblastoma in children: a 6-year retrospective study.
Zhang Y; Zhang WL; Huang DS; Hong L; Wang YZ; Zhu X; Hu HM; Zhang PW; Yi Y; Han T
Asian Pac J Cancer Prev; 2013; 14(8):4583-9. PubMed ID: 24083706
[TBL] [Abstract][Full Text] [Related]
15. The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model.
Czauderna P; Haeberle B; Hiyama E; Rangaswami A; Krailo M; Maibach R; Rinaldi E; Feng Y; Aronson D; Malogolowkin M; Yoshimura K; Leuschner I; Lopez-Terrada D; Hishiki T; Perilongo G; von Schweinitz D; Schmid I; Watanabe K; Derosa M; Meyers R
Eur J Cancer; 2016 Jan; 52():92-101. PubMed ID: 26655560
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of serum alpha-fetoprotein response during treatment of hepatoblastoma.
Koh KN; Park M; Kim BE; Bae KW; Kim KM; Im HJ; Seo JJ
Pediatr Blood Cancer; 2011 Oct; 57(4):554-60. PubMed ID: 21370433
[TBL] [Abstract][Full Text] [Related]
17. Children's Hepatic Tumors International Collaboration-Hepatoblastoma Stratification (CHIC-HS) System for Pediatric Patients with Hepatoblastoma: A Retrospective, Hospital-Based Cohort Study in South Korea.
Kim PH; Shin HJ; Yoon HM; Choi YH; Namgoong JM; Kim DY; Koh KN; Lee MJ; Yoon H; Lyu CJ; Han JW; Hahn SM; Cho YA
Cancer Res Treat; 2022 Jan; 54(1):253-258. PubMed ID: 33781052
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic and prognostic value of SALL4 in hepatoblastoma.
Zhou S; Venkatramani R; Gomulia E; Shillingford N; Wang L
Histopathology; 2016 Nov; 69(5):822-830. PubMed ID: 27252091
[TBL] [Abstract][Full Text] [Related]
19. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
Häberle B; Bode U; von Schweinitz D
Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
[TBL] [Abstract][Full Text] [Related]
20. Impact of postoperative complications on overall survival of patients with hepatoblastoma.
Becker K; Furch C; Schmid I; von Schweinitz D; Häberle B
Pediatr Blood Cancer; 2015 Jan; 62(1):24-8. PubMed ID: 25251521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
